Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2025-12-31 @ 12:26 AM
Study NCT ID:
NCT05598268
Status:
UNKNOWN
Last Update Posted:
2022-10-28
First Post:
2022-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.
Sponsor:
ImmVira Pharma Co. Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MVR-T3011-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None